Invention Application
- Patent Title: NEW CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
-
Application No.: US17606319Application Date: 2020-05-19
-
Publication No.: US20220213071A1Publication Date: 2022-07-07
- Inventor: Morten Jørgensen , Martin Juhl , Klaus Gjervig Jensen , Lisbet Kvænø
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Priority: DKPA201900608 20190521
- International Application: PCT/EP2020/063914 WO 20200519
- Main IPC: C07D405/12
- IPC: C07D405/12
Abstract:
The present invention provides compounds of formula (Id) that are prodrugs of catecholamine for use in treatment of neurodegenerative diseases and disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating neurodegenerative or neuropsychiatric diseases and disorders using the compounds of the invention, in particular Parkinson's disease.
Information query
